Lombard Odier Asset Management (USA)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
+2,406
| New | +$251K | 0.02% | 256 |
|
|
2017
Q1 | – | Sell |
-250,000
| Closed | -$1.69M | – | 157 |
|
|
2016
Q4 | $1.69M | Sell |
250,000
-78,061
| -24% | -$527K | 0.21% | 87 |
|
|
2016
Q3 | $2.59M | Sell |
328,061
-13,729
| -4% | -$108K | 0.24% | 98 |
|
|
2016
Q2 | $2.58M | Buy |
341,790
+9,400
| +3% | +$70.9K | 0.31% | 78 |
|
|
2016
Q1 | $2.86M | Sell |
332,390
-8,702
| -3% | -$74.8K | 0.39% | 93 |
|
|
2015
Q4 | $3.11M | Buy |
+341,092
| New | +$3.11M | 0.3% | 101 |
|